IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q1 2018 Holdings

Filed 2018-05-15 | 13 holdings | $3.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anavex Life Sciences Corp(AVXL)COM NEW032797300$2.0M724,20566.1%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$931.0K124,09630.8%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$33.9K2,359,7671.1%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$23.5K3,856,9850.8%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$19.3K749,8150.6%
Ampio Pharmaceuticals Inc.COM03209T109$8.8K2,595,4840.3%
Krystal Biotech Inc(KRYS)COM501147102$3.0K300,0000.1%
Vascular Biogenics LTDCOMM96883109$2.1K896,7710.1%
Soligenix Inc.COM834223307$1.6K837,8000.1%
Volition RX LTD(VNRX)COM928661107$844351,5380.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$74175,2380.0%
Evoke Pharma IncCOM30049G104$572275,0000.0%
Advaxis Inc.W EXP 07/15/201007624117$45112,5000.0%